Akebia Therapeutics Inc
Akebia Therapeutics Inc (AKBA) Implied Volatility Current
AKBA's 30 day implied volatility is 259.33%, with an IV Rank of 72.62%. This is a high IV Rank versus the past year, meaning Akebia Therapeutics Inc options are relatively expensive and currently favor sellers. AKBA's 30 day historical volatility sits at 185.64%, which means implied volatility is running 73.69 points above historical volatility, as of Nov 13, 2026.
Read more
Tracking AKBA implied volatility helps you spot when Akebia Therapeutics Inc options are historically cheap or expensive, and where the best trades are hiding. When AKBA IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor AKBA implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking AKBA IV rank helps you see whether AKBA's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis.
Implied Volatility
IV is highly elevated. Premiums are expensive, strongly favoring sellers.
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →